Meyka Pro banner
UnitedHealth Group Incorporated

UnitedHealth Group Incorporated (NYSE: UNH) Stock Competitors & Peer Comparison

See UNH's competitors and their performance on the NYSE and across the wider stock market.

UNHNYSE
HealthcareMedical - Healthcare Plans
$400.81
$1.38(0.34%)
U.S. Market is Open · 13:58

Peer Comparison Table: Medical - Healthcare Plans Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for UNH and its NYSE peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
UNH$400.81-0.34%368.4B24.82$16.34+2.21%
CVS$94.80-0.91%119.3B11.93$7.84+2.81%
ANTM$482.58+2.71%114.6B18.99$25.41+1.42%
ELV$399.37+2.31%86.6B13.58$29.39+1.73%
CI$277.62+1.37%73.3B8.98$30.90+2.21%
HUM$384.64+3.17%46.7B24.51$15.86+0.92%
CNC$66.45-0.18%32B25.74$2.52N/A
MOH$207.15+6.48%10.8B29.78$6.92N/A
OSCR$30.00+7.26%7.7B21.15$1.40N/A
ALHC$13.56+2.73%2.8B150.22$0.09N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CVS Health Corp. (NYSE: CVS)

UNH vs CVS Comparison August 2026

UnitedHealth Group Incorporated (NYSE: UNH) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, UNH stands at 368.4B. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, UNH is priced at $400.81 on the NYSE, while CVS trades at $94.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

UNH currently has a P/E ratio of 24.82, whereas CVS's P/E ratio is 11.93. In terms of profitability, UNH's ROE is +0.14%, compared to CVS's ROE of +0.06%. Regarding short-term risk, UNH is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for UNH.Check CVS's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions